MicroRNA-155 targets the SKI gene in human melanoma cell lines

Pigment Cell and Melanoma Research

Volumn 24, Issue 3, 2011, Pages 538-550

  Levati, Lauretta ^a   Pagani, Elena ^a   Romani, Sveva ^a   Castiglia, Daniele ^a   Piccinni, Eugenia ^a   Covaciu, Claudia ^a,b   Caporaso, Patrizia ^a   Bondanza, Sergio ^a   Antonetti, Francesca R ^a   Bonmassar, Enzo ^c   Martelli, Fabio ^a   Alvino, Ester ^d   D'Atri, Stefania ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF ORADEA   (Romania)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Cell growth; Melanoma; miR 155; SKI; Small interfering RNAs

Indexed keywords

MICRORNA; MICRORNA 155; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE INTERACTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA CELL; NUCLEOTIDE SEQUENCE; SKI TUMOR GENE; TUMOR GENE; UPREGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICRORNAS; PROTO-ONCOGENE PROTEINS; RNA, NEOPLASM;

EID: 79956058235     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2011.00857.x     Document Type: Article

References (66)

1. 6-methylguanine-DNA methyltransferase and the mismatch repair system. Int. J. Oncol. 29, 785-797.
2. Amiri, K.I., and Richmond, A. (2005). Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Rev. 24, 301-313.
3. Baud, V., and Karin, M. (2009). Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8, 33-40.
4. Bentwich, I., Avniel, A., Karov, Y. et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37, 766-770.
5. Bolisetty, M.T., Dy, G., Tam, W., and Beemon, K.L. (2009). Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J. Virol. 83, 12009-12017.
6. Bondanza, S., Maurelli, R., Paterna, P., Migliore, E., Giacomo, F.D., Primavera, G., Paionni, E., Dellambra, E., and Guerra, L. (2007). Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour. Pigment Cell Res. 20, 288-300.
7. Bushati, N., and Cohen, S.M. (2007). MicroRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205.
8. Caporali, S., Falcinelli, S., Starace, G., Russo, M.T., Bonmassar, E., Jiricny, J., and D'Atri, S. (2004). DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. Mol. Pharmacol. 66, 478-491.
9. Castiglia, D., Pagani, E., Alvino, E., Vernole, P., Marra, G., Cannavò, E., Jiricny, J., Zambruno, G., and D'Atri, S. (2003). Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma. Genes Chromosom. Cancer 37, 165-175.
10. Chen, D., Xu, W., Bales, E. et al. (2003). SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res. 63, 6626-6634.
11. Chen, D., Lin, Q., Box, N. et al. (2009). SKI knockdown inhibits human melanoma tumor growth in vivo. Pigment Cell Melanoma Res. 22, 761-772.
12. Chen, J., Feilotter, H.E., Paré, G.C., Zhang, X., Pemberton, J.G., Garady, C., Lai, D., Yang, X., and Tron, V.A. (2010). MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am. J. Pathol. 176, 2520-2529.
13. Colmenares, C., and Stavnezer, E. (1990). Structure and activities of the ski oncogene. Semin. Cancer Biol. 1, 383-387.
14. Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., and Croce, C.M. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103, 7024-7029.
15. Croce, C.M. (2009). Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10, 704-714.
16. Dahiya, N., Sherman-Baust, C.A., Wang, T.L., Davidson, B., Shih Ie, M., Zhang, Y., Wood, W. 3rd, Becker, K.G., and Morin, P.J. (2008). MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3, e2436.
17. Deheuninck, J., and Luo, K. (2009). Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res. 19, 47-57.
18. Dhawan, P., and Richmond, A. (2002). A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J. Biol. Chem. 277, 7920-7928.
19. Fecher, L.A., Cummings, S.D., Keefe, M.J., and Alani, R.M. (2007). Toward a molecular classification of melanoma. J. Clin. Oncol. 25, 1606-1620.
20. Filipowicz, W., Bhattacharyya, S.N., and Sonenberg, N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114.
21. Fumagalli, S., Doneda, L., Nomura, N., and Larizza, L. (1993). Expression of the c-ski proto-oncogene in human melanoma cell lines. Melanoma Res. 3, 23-27.
22. Gartel, A.L., and Kandel, E.S. (2008). miRNAs: little known mediators of oncogenesis. Semin. Cancer Biol. 18, 103-110.
23. Greither, T., Grochola, L.F., Udelnow, A., Lautenschläger, C., Würl, P., and Taubert, H. (2010). Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 126, 73-80.
24. Gulhati, P., Cai, Q., Li, J. et al. (2009). Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer. Clin. Cancer Res. 15, 7207-7216.
25. Guo, H., Ingolia, N.T., Weissma, J.S., and Bartel, D.P. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840.
26. Hresko, R.C., and Mueckler, M. (2005). mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406-40416.
27. Ibrahim, N., and Haluska, F.G. (2009). Molecular pathogenesis of cutaneous melanocytic neoplasms. Annu. Rev. Pathol. 4, 551-579.
28. Jiang, S., Zhang, H.W., Lu, M.H., He, X.H., Li, Y., Gu, H., Liu, M.F., and Wang, E.D. (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 70, 3119-3127.
29. John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C., and Marks, D.S. (2004). Human MicroRNA targets. PLoS Biol. 2, e363.
30. Jukic, D.M., Rao, U.N., Kelly, L., Skaf, J.S., Drogowski, L.M., Kirkwood, J.M., and Panelli, M.C. (2010). MicroRNA profiling analysis of differences between the melanoma of young adults and older adults. J. Transl. Med. 8, 27.
31. Kong, W., Yang, H., He, L., Zhao, J.J., Coppola, D., Dalton, W.S., and Cheng, J.Q. (2008). MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28, 6773-6784.
32. Kong, W., He, L., Coppola, M., Guo, J., Esposito, N.N., Coppola, D., and Cheng, J.Q. (2010). MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J. Biol. Chem. 285, 17869-17879.
33. Krek, A., Grün, D., Poy, M.N. et al. (2005). Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500.
34. Levati, L., Alvino, E., Pagani, E. et al. (2009). Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miR-155. Int. J. Oncol. 35, 393-400.
35. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., and Burge, C.B. (2003). Prediction of mammalian microRNA targets. Cell 115, 787-798.
36. -ΔΔCT Method. Methods 25, 402-408.
37. Martin, M.M., Lee, E.J., Buckenberger, J.A., Schmittgen, T.D., and Elton, T.S. (2006). MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem. 281, 18277-18284.
38. Masri, J., Bernath, A., Martin, J., Jo, O.D., Vartanian, R., Funk, A., and Gera, J. (2007). mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res. 67, 11712-11720.
39. Mayr, C., and Bartel, D.P. (2009). Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673-684.
40. Medrano, E.E. (2003). Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 22, 3123-3129.
41. Mills, C.N., Joshi, S.S., and Niles, R.M. (2009). Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mol. Cancer 8, 104.
42. Mueller, D.W., and Bosserhoff, A.K. (2009). Role of miRNAs in the progression of malignant melanoma. Br. J. Cancer 101, 551-556.
43. Nagata, M., Goto, K., Ehata, S., Kobayashi, N., Saitoh, M., Miyoshi, H., Imamura, T., Miyazawa, K., and Miyazono, K. (2006). Nuclear and cytoplasmic c-Ski differently modulate cellular functions. Genes Cells 11, 1267-1280.
44. Nicoloso, M.S., Spizzo, R., Shimizu, M., Rossi, S., and Calin, G.A. (2009). MicroRNAs - the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293-302.
45. O'Connell, R.M., Rao, D.S., Chaudhuri, A.A., Boldin, M.P., Taganov, K.D., Nicoll, J., Paquette, R.L., and Baltimore, D. (2008). Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205, 585-594.
46. O'Connell, R.M., Chaudhuri, A.A., Rao, D.S., and Baltimore, D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106, 7113-7118.
47. Philippidou, D., Schmitt, M., Moser, D., Margue, C., Nazarov, P.V., Muller, A., Vallar, L., Nashan, D., Behrmann, I., and Kreis, S. (2010). Signature of microRNA and selected microRNA target genes in human melanoma. Cancer Res. 70, 4163-4173.
48. Rankin, E.B., and Giaccia, A.J. (2008). The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15, 678-685.
49. Reed, J.A., Bales, E., Xu, W., Okan, N.A., Bandyopadhyay, D., and Medrano, E.E. (2001). Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res. 61, 8074-8078.
50. Reed, J.A., Lin, Q., Chen, D., Mian, I.S., and Medrano, E.E. (2005). SKI pathways inducing progression of human melanoma. Cancer Metastasis Rev. 24, 265-272.
51. Roldo, C., Missiaglia, E., Hagan, J.P. et al. (2006). MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 24, 4677-4684.
52. Romania, P., Lulli, V., Pelosi, E., Biffoni, M., Peschle, C., and Marziali, G. (2008). MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br. J. Haematol. 143, 570-580.
53. Rothhammer, T., and Bosserhoff, A.K. (2006). Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma. Melanoma Res. 16, 309-316.
54. Sarbassov, D.D., Guertin, D.A., Ali, S.M., and Sabatini, D.M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
55. Segura, M.F., Belitskaya-Levy, I., Rose, A.E. et al. (2010). Melanoma microRNA signature predicts post-recurrence survival. Clin. Cancer Res. 16, 1577-1586.
56. Semenza, G.L. (2010). Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625-634.
57. Stefani, G., and Slack, F.J. (2008). Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 9, 219-230.
58. Topalian, S.L., Solomon, D., and Rosenberg, S.A. (1989). Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 142, 3714-3725.
59. Trang, P., Weidhas, J.B., and Slack, F.J. (2009). MicroRNA as potential cancer therapeutics. Oncogene 27, S52-S57.
60. Valeri, N., Gasparini, P., Fabbri, M. et al. (2010). Modulation of mismatch repair and genomic stability by miR-155. Proc. Natl. Acad. Sci. USA 107, 6982-6987.
61. Werzowa, J., Cejka, D., Fuereder, T., Dekrout, B., Thallinger, C., Pehamberger, H., Wacheck, V., and Pratscher, B. (2009). Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002. Br. J. Dermatol. 160, 955-964.
62. Williams, A.E. (2008). Functional aspects of animal microRNAs. Cell. Mol. Life Sci. 65, 545-562.
63. Winter, J., Jung, S., Keller, S., Gregory, R.I., and Diederichs, S. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228-234.
64. Yanaihara, N., Caplen, N., Bowman, E. et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198.
65. Zhang, B., Wang, Q., and Pan, X. (2007). MicroRNAs and their regulatory roles in animals and plants. J. Cell. Physiol. 210, 279-289.
66. Zhao, Y., and Srivastava, D. (2007). A developmental view of microRNA function. Trends Biochem. Sci. 32, 189-197.